Vaxcyte, Inc. SEC filings PCVX

Vaxcyte, Inc. has 767 filings in SEC EDGAR's recent list, going back to Jul 24, 2015. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Vaxcyte, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
8-K Current report
Material agreement, New debt, Other events
Oct 9, 2026 Oct 6, 2026
424B5 Prospectus supplement Oct 8, 2026 —
424B5 Prospectus supplement Oct 8, 2026 —
4 Insider transaction Oct 7, 2026 Oct 5, 2026
4 Insider transaction Oct 7, 2026 Oct 5, 2026
FWP Free writing prospectus Oct 7, 2026 —
305B2 Filing Oct 6, 2026 —
424B5 Prospectus supplement Oct 6, 2026 —
424B5 Prospectus supplement Oct 6, 2026 —
144 Notice of proposed sale Oct 5, 2026 —
144 Notice of proposed sale Oct 5, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Oct 5, 2026 Oct 5, 2026
4 Insider transaction Oct 2, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
3 Initial insider ownership Sep 9, 2026 Aug 31, 2026
144 Notice of proposed sale Sep 9, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 3, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
144 Notice of proposed sale Sep 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
4 Insider transaction Aug 5, 2026 Aug 5, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
144 Notice of proposed sale Aug 5, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
4 Insider transaction Jul 28, 2026 Jul 27, 2026
144 Notice of proposed sale Jul 27, 2026 —
4 Insider transaction Jul 16, 2026 Jul 16, 2026
3 Initial insider ownership Jul 16, 2026 Jul 16, 2026
8-K Current report
Officer or director change
Jul 15, 2026 Jul 13, 2026
4 Insider transaction Jul 6, 2026 Jul 6, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 6, 2026 —
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 26, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 23, 2026 Jun 22, 2026
3 Initial insider ownership Jun 23, 2026 Jun 17, 2026
8-K Current report
Officer or director change
Jun 23, 2026 Jun 17, 2026
4 Insider transaction Jun 18, 2026 Jun 18, 2026
4 Insider transaction Jun 18, 2026 Jun 18, 2026
144 Notice of proposed sale Jun 18, 2026 —
144 Notice of proposed sale Jun 18, 2026 —
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
8-K Current report
Shareholder vote results
Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
4 Insider transaction May 1, 2026 May 1, 2026
144 Notice of proposed sale May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 15, 2026
4 Insider transaction Apr 8, 2026 Apr 7, 2026
144 Notice of proposed sale Apr 7, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 18, 2026 Mar 17, 2026
144 Notice of proposed sale Mar 17, 2026 —
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
144 Notice of proposed sale Mar 11, 2026 —
144 Notice of proposed sale Mar 10, 2026 —
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
8-K Current report
Other events
Feb 24, 2026 Feb 24, 2026
424B5 Prospectus supplement Feb 24, 2026 —
S-8 Employee stock plan registration Feb 24, 2026 —
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Other events
Feb 2, 2026 Jan 29, 2026
424B5 Prospectus supplement Jan 30, 2026 —
424B5 Prospectus supplement Jan 29, 2026 —
4 Insider transaction Jan 16, 2026 Jan 14, 2026
4 Insider transaction Jan 16, 2026 Jan 14, 2026
4 Insider transaction Jan 16, 2026 Jan 15, 2026
4 Insider transaction Jan 2, 2026 Dec 31, 2025
144 Notice of proposed sale Dec 31, 2025 —
4 Insider transaction Dec 29, 2025 Dec 23, 2025
144 Notice of proposed sale Dec 23, 2025 —
8-K Current report
Officer or director change
Dec 19, 2025 Dec 18, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Material agreement
Sep 30, 2025 Sep 24, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 8, 2025 —
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Aug 29, 2025 Aug 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
UPLOAD Letter from the SEC May 14, 2025 —
CORRESP Letter to the SEC May 7, 2025 —
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
4 Insider transaction May 2, 2025 May 1, 2025
3 Initial insider ownership May 2, 2025 May 1, 2025
8-K Current report
Officer or director change
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 12, 2025
3 Initial insider ownership Apr 25, 2025 Apr 17, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
UPLOAD Letter from the SEC Apr 10, 2025 —
4 Insider transaction Apr 10, 2025 Apr 8, 2025
4 Insider transaction Apr 9, 2025 Apr 7, 2025
4 Insider transaction Apr 7, 2025 Apr 4, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 31, 2025 Mar 31, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Dec 31, 2024
4 Insider transaction Mar 3, 2025 Feb 27, 2025
144 Notice of proposed sale Mar 3, 2025 —
S-8 Employee stock plan registration Feb 25, 2025 —
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
4 Insider transaction Feb 19, 2025 Feb 18, 2025
144 Notice of proposed sale Feb 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Feb 7, 2025 Feb 5, 2025
144 Notice of proposed sale Feb 5, 2025 —
4 Insider transaction Feb 4, 2025 Feb 3, 2025
144 Notice of proposed sale Feb 3, 2025 —
4 Insider transaction Jan 22, 2025 Jan 21, 2025
144 Notice of proposed sale Jan 21, 2025 —
4 Insider transaction Jan 17, 2025 Jan 15, 2025
144 Notice of proposed sale Jan 15, 2025 —
4 Insider transaction Jan 7, 2025 Jan 6, 2025
144 Notice of proposed sale Jan 6, 2025 —
4 Insider transaction Jan 3, 2025 Jan 2, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
PCVX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Carlos, CA
SEC filer status
Large accelerated filer
SEC CIK
1649094
Former names
SutroVax, Inc. (until Apr 3, 2020)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.